Literature DB >> 12691834

Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism.

Donard S Dwyer1, Xiao-Hong Lu, Ronald J Bradley.   

Abstract

The goal of these studies was to analyze the cytotoxicity of both the conventional and atypical antipsychotic drugs in relation to their effects on glucose metabolism. The drugs were evaluated for their effects on the viability of PC12 cells, which are an established model of neuronal cells in culture. In general, the conventional drugs, such as chlorpromazine, fluphenazine and pimozide, were more toxic than the atypical drugs, including clozapine, quetiapine and risperidone. Olanzapine was unique in that it stimulated cell proliferation in this system. There was a good correlation between the cytotoxicity of a drug and its ability to block glucose transport, although there were some exceptions to this trend. Conventional antipsychotics also affected the expression of glucose transporter proteins in whole cell extracts and at the cell surface. Overall, the data support the notion that many of the antipsychotic drugs associated with the development of movement disorders in patients are cytotoxic for cultured cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12691834     DOI: 10.1016/s0006-8993(03)02351-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  14 in total

Review 1.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

Review 2.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

Review 3.  Pharming for Genes in Neurotransmission: Combining Chemical and Genetic Approaches in Caenorhabditis elegans.

Authors:  Stephen M Blazie; Yishi Jin
Journal:  ACS Chem Neurosci       Date:  2018-03-06       Impact factor: 4.418

4.  Effects of aripiprazole and clozapine on the treatment of glycolytic carbon in PC12 cells.

Authors:  Akira Ota; Akira Nakashima; Yoko S Kaneko; Keiji Mori; Hiroshi Nagasaki; Takeshi Takayanagi; Mitsuyasu Itoh; Kazunao Kondo; Toshiharu Nagatsu; Miyuki Ota
Journal:  J Neural Transm (Vienna)       Date:  2012-03-04       Impact factor: 3.575

5.  Antipsychotic drugs disrupt normal development in Caenorhabditis elegans via additional mechanisms besides dopamine and serotonin receptors.

Authors:  Dallas R Donohoe; Eric J Aamodt; Elizabeth Osborn; Donard S Dwyer
Journal:  Pharmacol Res       Date:  2006-08-07       Impact factor: 7.658

6.  Autophagy inhibition uncovers the neurotoxic action of the antipsychotic drug olanzapine.

Authors:  Ljubica Vucicevic; Maja Misirkic-Marjanovic; Verica Paunovic; Tamara Kravic-Stevovic; Tamara Martinovic; Darko Ciric; Nadja Maric; Sasa Petricevic; Ljubica Harhaji-Trajkovic; Vladimir Bumbasirevic; Vladimir Trajkovic
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

7.  Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways.

Authors:  Xiao-Hong Lu; Donard S Dwyer
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

8.  Fatty acid transport protein-2 inhibitor Grassofermata/CB5 protects cells against lipid accumulation and toxicity.

Authors:  Nipun Saini; Paul N Black; David Montefusco; Concetta C DiRusso
Journal:  Biochem Biophys Res Commun       Date:  2015-08-15       Impact factor: 3.575

9.  Structure-based discovery of low molecular weight compounds that stimulate neurite outgrowth and substitute for nerve growth factor.

Authors:  Britney Williams; Donard S Dwyer
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

10.  A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

Authors:  John W Newcomer; Robert E Ratner; Jan W Eriksson; Robin Emsley; Didier Meulien; Frank Miller; Julia Leonova-Edlund; Ronald W Leong; Martin Brecher
Journal:  J Clin Psychiatry       Date:  2009-04-07       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.